wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41665025-0A98812E-244B-4099-BEE1-5B9B823A8889
Q41665025-0A98812E-244B-4099-BEE1-5B9B823A8889
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41665025-0A98812E-244B-4099-BEE1-5B9B823A8889
Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.
P2860
Q41665025-0A98812E-244B-4099-BEE1-5B9B823A8889
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41665025-0A98812E-244B-4099-BEE1-5B9B823A8889
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
635238040b1c6a03129cc5bdd66e03ff430b35a9
P2860
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.